GYRE
Gyre Therapeutics Inc.
NASDAQ: GYRE · HEALTHCARE · BIOTECHNOLOGY
$7.68
+4.49% today
Updated 2026-04-30
Market cap
$696.73M
P/E ratio
381.50
P/S ratio
5.98x
EPS (TTM)
$0.02
Dividend yield
—
52W range
$7 – $12
Volume
0.1M
Gyre Therapeutics Inc. (GYRE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.89M | $24.84M | $-28.26M | $-24.27M | $138.30M | $-83.72M | $-64.24M | $-40.61M | $-34.48M | $-19.12M | $-18.47M | $-19.94M | $-28.55M | $-43.61M | $-55.05M | $-83.75M | $10.68M | $25.89M | $-3.64M | $1.01M |
| Capital expenditures | $1.08M | $4.94M | $2.05M | $200000.00 | $3.31M | $1.43M | $333000.00 | $92000.00 | $4000.00 | $272000.00 | $468000.00 | $23000.00 | $376000.00 | $64000.00 | $267000.00 | $839000.00 | $5.00M | $8.59M | $3.13M | $1.19M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $918.52M | $2.75B | $2.06M | $2.45M | $4.94M | $8.51M | $7.85M | $5.22M | $3.47M | $326000.00 | $635000.00 | $863000.00 | $2.61M | $3.20M | $3.63M | $3.40M | $13.37M | $7.28M | $831000.00 | $7.16M |
| Free cash flow | $-10.97M | $19.89M | $-30.31M | $-24.47M | $134.99M | $-85.15M | $-64.57M | $-40.70M | $-34.49M | $-19.39M | $-18.94M | $-19.96M | $-28.93M | $-43.68M | $-55.31M | $-84.59M | $5.68M | $17.31M | $-6.77M | $-180000.00 |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $3.95M | — | — | — | $0.00 | $45.03M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |